2023
DOI: 10.1016/j.biopha.2023.114256
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning-based models for genomic predicting neoadjuvant chemotherapeutic sensitivity in cervical cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…The MDI indicates the degree of impurity (classification capability) for each variable according to the GINI index, which measures the probability of a particular variable being wrongly classified when it is randomly chosen. This algorithm has been selected because of its ability to assign the importance of biological features [ 11 , 23 , 24 ]. Furthermore, in a previous work in which various feature selection algorithms were compared, the MDI-based approach was one of the best performing [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…The MDI indicates the degree of impurity (classification capability) for each variable according to the GINI index, which measures the probability of a particular variable being wrongly classified when it is randomly chosen. This algorithm has been selected because of its ability to assign the importance of biological features [ 11 , 23 , 24 ]. Furthermore, in a previous work in which various feature selection algorithms were compared, the MDI-based approach was one of the best performing [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…Additionally, the PI3K/AKT pathway has been identified as a pivotal regulator of chemosensitivity. Genetic variations in Akt1, Akt2, and PIK3CA have been identified as being associated with chemosensitivity in cervical cancer patients [ 6 ]. Furthermore, andrographolide, a potential therapeutic agent in gastric cancer, deactivates the HIF-1 signaling pathway by inhibiting the upstream PI3K-AKT pathway.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies collectively suggest that the peroxisome proliferator-activated receptor gamma (PPARG) interacts with the PTEN-PI3K/AKT signaling pathway, playing a crucial role in regulating chemosensitivity in various cancers, including HSCC [5][6][7][8]. One study discovered that PPARG expression levels were slightly downregulated in chemotherapy-sensitive HSCC patients, indicating a potential association between PPARG and chemosensitivity [9].…”
Section: Introductionmentioning
confidence: 99%